US Stock MarketDetailed Quotes

MGNX Macrogenics

Watchlist
  • 1.730
  • +0.020+1.17%
Trading Apr 24 14:56 ET
109.15MMarket Cap-1.62P/E (TTM)

About Macrogenics Company

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.

Company Profile

SymbolMGNX
Company NameMacrogenics
Listing DateOct 10, 2013
Issue Price16.00
Founded2000
CEODr. Scott Koenig, M.D.,PhD
MarketNASDAQ
Employees341
Fiscal Year Ends12-31
Address9704 Medical Center Drive
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850-3368
Phone1-301-251-5172
Websitehttp://www.macrogenics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Scott Koenig, M.D.,PhD
  • Director, President and Chief Executive Officer
  • 6.40M
  • James Karrels
  • Senior Vice President, Chief Financial Officer and Corporate Secretary
  • 2.37M
  • Eric Risser
  • Chief Operating Officer
  • --
  • Dr. Stephen L. Eck, M.D.,PhD
  • Senior Vice President, Clinical Development and Chief Medical Officer
  • 2.65M
  • Dr. Ezio Bonvini, M.D.
  • Senior Vice President, Research and Chief Scientific Officer
  • --
  • Beth Smith
  • Vice President, Controller, Treasurer and Principal Accounting Officer
  • --
  • Jeffrey Stuart Peters
  • Senior Vice President, General Counsel and Corporate Compliance Officer
  • --
  • Dr. Thomas Spitznagel, PhD
  • Senior Vice President, Technical Operations
  • --
  • William K. Heiden
  • Chairman of the Board
  • 304.72K
  • Meenu Chhabra Karson
  • Independent Director
  • 150.69K
  • Federica O'Brien
  • Independent Director
  • 170.63K
  • Scott T. Jackson, M.B.A.
  • Independent Director
  • 151.57K
  • Edward M. Hurwitz, J.D.
  • Independent Director
  • 145.63K
  • Dr. Margaret A. Liu, M.D.
  • Independent Director
  • 145.01K
  • Dr. Karen Jean Ferrante, M.D.
  • Independent Director
  • 145.63K
  • Dr. Jay Siegel, M.D.
  • Independent Director
  • 144.38K
  • Dr. David C. Stump,M.D.
  • Independent Director
  • 155.63K

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Bakkt Holdings
BKKT
10.050
TeraWulf
WULF
3.040
Mawson Infrastructure
MIGI
0.4589
4
Ebang International
EBON
3.614
5
Bitdeer Technologies
BTDR
10.425
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.